Psychiatry and Clinical Psychopharmacology

Schizophrenia and other psychotic disorders Prolidase activity and oxidative stress in patients with schizophrenia

Psychiatry and Clinical Psychopharmacology 2013; 23: Supplement S269-S269
Read: 543 Published: 17 March 2021

Objective: Our aim is to determine whether the serum prolidase levels are associated with the etiopathogenesis of schizophrenia.

Methods: This study included 30 patients with schizophrenia, who were consecutively recruited from psychiatry outpatient clinics at the university hospital and 30 healthy individuals recruited from community. Each patient underwent a detailed diagnostic evaluation by psychiatry residents by using The Structured Clinical Interviews for DSM-IV (SCID-I). Serum prolidase activity and oxidative parameters was measured in patient and control groups. The severity of psychotic symptoms was assessed using the positive and negative syndrome scale (PANSS).

Results: Serum prolidase level was significantly higher in schizophrenia patients compared to healthy subjects (p<0.001). Oxidative stress parameters were found significantly difference between schizophrenia patients and healthy subjects. Serum prolidase level did not show any correlation with markers of oxidative stress in patients.

Conclusion: Prolidase activity, glutamate transmission and oxidative stress may be inter-related in the etio-pathogenesis of schizophrenia.

EISSN 2475-0581